Kenya - English - Pharmacy and Poisons Board

reddys pharma limited off mombasa road, masai road, nairobi kenya - fluphenazine decanoate bp - injection - fluphenazine decanoate bp 25mg/ml - fluphenazine

United States - English - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - pentazocine hydrochloride (unii: a36bxo4ppx) (pentazocine - unii:rp4a60d26l) - pentazocine 50 mg

Canada - English - Health Canada

pharmascience inc - fluphenazine decanoate - liquid - 25mg - fluphenazine decanoate 25mg - phenothiazines

Canada - English - Health Canada

pharmascience inc - fluphenazine decanoate - liquid - 100mg - fluphenazine decanoate 100mg - phenothiazines

United States - English - NLM (National Library of Medicine)

american health packaging - perphenazine (unii: fta7xxy4ez) (perphenazine - unii:fta7xxy4ez) - perphenazine 2 mg

United States - English - NLM (National Library of Medicine)

clinical solutions wholesale - perphenazine (unii: fta7xxy4ez) (perphenazine - unii:fta7xxy4ez) - perphenazine 2 mg

United States - English - NLM (National Library of Medicine)

cardinal health - perphenazine (unii: fta7xxy4ez) (perphenazine - unii:fta7xxy4ez) - perphenazine 2 mg

United States - English - NLM (National Library of Medicine)

clinical solutions wholesale, llc - perphenazine (unii: fta7xxy4ez) (perphenazine - unii:fta7xxy4ez) - perphenazine 2 mg

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - perphenazine (unii: fta7xxy4ez) (perphenazine - unii:fta7xxy4ez) - perphenazine is indicated for use in the treatment of schizophrenia and for the control of severe nausea and vomiting in adults. perphenazine has not been shown effective for the management of behavioral complications in patients with mental retardation. perphenazine products are contraindicated in comatose or greatly obtunded patients and in patients receiving large doses of central nervous system depressants (barbiturates, alcohol, narcotics, analgesics, or antihistamines); in the presence of existing blood dyscrasias, bone marrow depression, or liver damage; and in patients who have shown hypersensitivity to perphenazine products, their components, or related compounds. perphenazine products are also contraindicated in patients with suspected or established subcortical brain damage, with or without hypothalamic damage, since a hyperthermic reaction with temperatures in excess of 104°f may occur in such patients, sometimes not until 14 to 16 hours after drug administration. total body ice-packing is recommended for such a reaction; antipyretics may also be useful.

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - perphenazine (unii: fta7xxy4ez) (perphenazine - unii:fta7xxy4ez) - perphenazine is indicated for use in the treatment of schizophrenia and for the control of severe nausea and vomiting in adults. perphenazine has not been shown effective for the management of behavioral complications in patients with mental retardation. perphenazine products are contraindicated in comatose or greatly obtunded patients and in patients receiving large doses of central nervous system depressants (barbiturates, alcohol, narcotics, analgesics, or antihistamines); in the presence of existing blood dyscrasias, bone marrow depression, or liver damage; and in patients who have shown hypersensitivity to perphenazine products, their components, or related compounds. perphenazine products are also contraindicated in patients with suspected or established subcortical brain damage, with or without hypothalamic damage, since a hyperthermic reaction with temperatures in excess of 104°f may occur in such patients, sometimes not until 14 to 16 hours after drug administration. total body ice-packing is recomme